STAT
SEPTEMBER 14, 2023
Long Covid goes by many names. Today, it is no longer a new public health enigma, but the outlook for sufferers is no better than when the condition was first recognized in early 2020. Although its prevalence has recently decreased to 6% of the U.S. adult population, there has been no significant progress in understanding its causes, prevention, or treatment.
PharmaVoice
SEPTEMBER 14, 2023
The French pharma’s latest vaccine campaign aims to raise awareness about the flu’s complications for marginalized groups.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 14, 2023
For 40 years, researchers have unsuccessfully tried to explain — or debunk — the “Hispanic Paradox,” the finding that Hispanic Americans live several years longer than white Americans on average, despite having far less income and health care and higher rates of diabetes and obesity. Now, armed with more comprehensive data, powerful genomic tools, and a rich cultural awareness of the communities they study, a new generation of scientists is finally making headway.
PharmaVoice
SEPTEMBER 14, 2023
Reimbursement challenges have created barriers for new dialysis products, according to the chief commercial officer of CorMedix.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 14, 2023
John Green, a novelist and high-profile YouTuber, is once again leveraging his star power in the global fight to end tuberculosis. His latest target? The diagnostics company Cepheid and the price of its tuberculosis test, GeneXpert. Cepheid sells individual test cartridges for $9.98 each, which lab technicians can analyze in a speedy machine that is also sold by the company.
The Pharmacist
SEPTEMBER 14, 2023
Community pharmacies in Scotland will be able to participate in a national naloxone emergency supply service from the end of next month. The Royal Pharmaceutical Society (RPS) in Scotland described the move as a ‘huge step forwards’ in making naloxone, which is used to reverse the effects of an opioid overdose, available in all clinical […] The post Scotland introduces national naloxone emergency supply appeared first on The Pharmacist.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
SEPTEMBER 14, 2023
Nicotine vaping is the most effective among widely available smoking cessation aids, researchers have declared. Cytisine and varenicline are also among the most effective tools to help people stop smoking, although these are not widely available, say researchers. Combination nicotine replacement therapies (NRT) – for example combining a patch with gum – were almost nearly […] The post Nicotine vaping is most effective smoking cessation aid, say researchers appeared first on The Pharmacist.
STAT
SEPTEMBER 14, 2023
NEW YORK — Dozens of doctors and nurses silently lined the hospital hallway in tribute: For a history-making two months, a pig’s kidney worked normally inside the brain-dead man on the gurney rolling past them. The dramatic experiment came to an end Wednesday as surgeons at NYU Langone Health removed the pig kidney and returned the donated body of Maurice “Mo” Miller to his family for cremation.
The Pharmacist
SEPTEMBER 14, 2023
Community pharmacy should be included in any local planning meetings around vaccinations in future pandemics, the National Pharmacy Association (NPA) told the Covid public inquiry this week. The sector must be included from the outset in any discussions including supply and resourcing of a vaccination service, the community pharmacy body said in the latest public […] The post Include pharmacy in future pandemic vaccination planning, urges NPA appeared first on The Pharmacist.
STAT
SEPTEMBER 14, 2023
MDMA is a safe and effective treatment for post-traumatic stress disorder in a racially and ethnically diverse population, according to the results of a study published Thursday in Nature Medicine. The research adds to the growing body of evidence supporting MDMA as a treatment for PTSD, and brings the psychedelic one step closer to potentially becoming the first to obtain Food and Drug Administration approval.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
SEPTEMBER 14, 2023
The report highlights steps needed to ensure future pandemics are handled effectively - News - PharmaTimes
STAT
SEPTEMBER 14, 2023
The U.S. government should monitor the effect that rebates have on Medicare Part D plans and whether these discounts ultimately discourage some people from enrolling in the prescription drug program, according to a new report by a federal watchdog. At issue is the opaque pharmaceutical pricing system. To win coveted placement on formularies – the list of medicines covered by insurers – drug companies pay rebates to Medicare Part D and commercial health plans.
PharmExec
SEPTEMBER 14, 2023
Lung-I Cheng, vice president of cell and gene therapy (CGT), Cencora (formerly AmerisourceBergen), discusses CGT commercialization strategies, common knowledge gaps, and what he wishes companies knew about commercialization strategies.
STAT
SEPTEMBER 14, 2023
What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants.
Amber
SEPTEMBER 14, 2023
OMAHA, Neb. (Sept. 14, 2023) – In honor of Amber Specialty Pharmacy’s 25th anniversary, the specialty pharmacy provider has launched Vitality, a new six-month transplant recovery program to help support patients and caregivers during the post-transplant period, which is considered the most critical time for those patients. The new Vitality program helps support patients through billing, medications, dietitian support and patient outreach.
STAT
SEPTEMBER 14, 2023
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry, the latest effort by the federal government to scrutinize patent moves by drugmakers. In explaining its new policy statement , the FTC noted that some drug companies have failed to follow requirements for listing patents in the so-called Orange Book in hopes of thwarting competition from lower-cost generic m
BioPharma Dive
SEPTEMBER 14, 2023
Since 2019, Generate has raised nearly $700 million in private financing and has now brought a monoclonal antibody into Phase 1 testing.
STAT
SEPTEMBER 14, 2023
WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies. Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary , ProvideGx, with the same aim.
European Pharmaceutical Review
SEPTEMBER 14, 2023
Under a new agreement, AstraZeneca is set to establish the first unsubsidised industrial-scale supply of biomethane. The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharma manufacturing site.
STAT
SEPTEMBER 14, 2023
WASHINGTON — A House subcommittee took a first step Thursday toward legislation to fix drug shortages at hospitals. Don’t expect a new law soon, though. Asked if he expects the House to pass a bill on the subject this year, Energy and Commerce health subcommittee Chair Brett Guthrie (R-Ky.) said drug shortages are an emergency, “but the proposals that have been offered aren’t going to fix it by tomorrow or the next day.
World Pharma News
SEPTEMBER 14, 2023
GSK and Save the Children have announced today that they are renewing their award-winning partnership for a further five years. GSK will invest £15 million in the partnership with Save the Children and they will work together to increase child vaccination rates, with a focus on reducing the number of 'zero dose' children in Ethiopia and Nigeria.
STAT
SEPTEMBER 14, 2023
WASHINGTON — A new, bipartisan deal in the Senate to fund primary care programs also includes new policies to restrain hospital costs, including a ban on some facility fees and restrictions on anticompetitive contracting practices. The package, negotiated between Senate health committee Chair Bernie Sanders (I-Vt.) and Sen. Roger Marshall (R-Kan.), is urgent because it includes funding for community health centers that is set to expire at the end of the month.
European Pharmaceutical Review
SEPTEMBER 14, 2023
Rimegepant (Vydura) is the “first and only NICE-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment,” shared Helen Knight, Director of medicines evaluation at the National Institute for Health and Care Excellence (NICE). Made by Pfizer, Rimegepant (Vydura), is recommended in NICE final draft guidance for adults who have tried at least two triptans but failed to achieve adequate relief with these medicines.
STAT
SEPTEMBER 14, 2023
Johnson & Johnson is signing off on a new logo. The health care giant said Thursday that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices.
Pharma Times
SEPTEMBER 14, 2023
The funding will reduce waiting lists and ease the demand on the NHS during Winter - News - PharmaTimes
BioPharma Dive
SEPTEMBER 14, 2023
The company is working on a treatment of alpha-1 antitrypsin deficiency, which it claims it can deliver direct to lung cells via a nebulizer.
PharmaTech
SEPTEMBER 14, 2023
The companies are collaborating to apply ShapeTX’s AAVid capsid discovery platform and transgene engineering technology in addition to Otsuka’s expertise in genetic payload design and ophthalmology to develop novel treatment options for eye diseases.
Outsourcing Pharma
SEPTEMBER 14, 2023
The U.S. company Rome Therapeutics plans to use the proceeds of its $72 million Series B round to take an experimental autoimmune disease treatment through early clinical testing.
The Pharmacist
SEPTEMBER 14, 2023
Antibiotics should not be prescribed for a suspected acute respiratory infection (ARI) based on a remote consultation only, NICE has proposed in a new draft guideline. The draft guideline on the initial assessment and management of suspected ARIs in over-16s covers pneumonia, respiratory viruses, and flu – but not Covid-19. NICE is expecting the final guideline to […] The post Antibiotics should not be prescribed remotely for respiratory infections, says NICE appeared first on The Pharmaci
Outsourcing Pharma
SEPTEMBER 14, 2023
Insilico Medicine is due to receive $80 million upfront plus potential milestone payments as Exelixis gains global rights to develop and commercialize the Hong Kong firmâs small molecule cancer treatment.
pharmaphorum
SEPTEMBER 14, 2023
Before you start the strategic planning cycle: 5 essential things to streamline your approach Mike.
Outsourcing Pharma
SEPTEMBER 14, 2023
A partnership deal between the Dutch digital health company Congenica and clinical trial platform provider myTomorrows will see the companies pooling their technologies to help more patients receive precision oncology treatments.
pharmaphorum
SEPTEMBER 14, 2023
From the Margins: Gilead book launch shines light on health inequalities Mike.
BioPharma Dive
SEPTEMBER 14, 2023
Pricing of the companies’ IPOs comes after a big day for Wall Street, which saw the SoftBank-owned chip maker Arm pull off the year’s largest new stock offering.
pharmaphorum
SEPTEMBER 14, 2023
Akili exits the prescription DTx market, slashing staff Phil.
Expert insights. Personalized for you.
364 
Let's personalize your content